Tucker Asset Management’s AstraZeneca AZN Stock Holding History

Tucker Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$186K	Buy	+1,013	New	+$178K	0.05%	121
2025 Q1	–	Sell	-1,694	Closed	-$222K	–	366
2024 Q4	$222K	Buy	1,694 +316	+23%	+$44.2K	0.02%	123
2024 Q3	$215K	Buy	1,378 +270	+24%	+$43.6K	0.05%	135
2024 Q2	$173K	Buy	1,108 +1,093	+7,287%	+$164K	0.04%	178
2024 Q1	$2.03K	Sell	15 -21	-58%	-$2.78K	﹤0.01%	1308
2023 Q4	$4.78K	Sell	36 -2	-5%	-$260	﹤0.01%	926
2023 Q3	$5.08K	Hold	38	–	–	﹤0.01%	818
2023 Q2	$5.37K	Sell	38 -412	-92%	-$60.6K	﹤0.01%	663
2023 Q1	$62.4K	Buy	450 +427	+1,857%	+$57.4K	0.02%	215
2022 Q4	$3.06K	Hold	23	–	–	﹤0.01%	506
2022 Q3	$2.65K	Buy	23 +2	+10%	+$254	﹤0.01%	527
2022 Q2	$2.71K	Hold	21	–	–	﹤0.01%	417
2022 Q1	$2.72K	Buy	+21	New	+$2.52K	﹤0.01%	390

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tucker Asset Management's AZN Position: Q4 2025 in Review

Tucker Asset Management opened a new position in AstraZeneca (AZN) in Q4 2025: 1,013 shares worth $186K. The stake represents 0.05% of the portfolio and ranks #121 among its holdings. This is a return to the name: Tucker Asset Management previously reported a position in AZN as recently as Q4 2024.

Tucker Asset Management first reported a position in AZN in Q1 2022 and has held it in 13 quarters since. The position peaked at $222K in Q4 2024. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Tucker Asset Management held 1,013 shares of AstraZeneca worth $186K as of Q4 2025.
AstraZeneca was a new Tucker Asset Management position in Q4 2025.
AstraZeneca made up 0.05% of Tucker Asset Management's portfolio in Q4 2025, its #121 holding.
Tucker Asset Management first reported a position in AstraZeneca in Q1 2022 and has held it in 13 quarters since.
Tucker Asset Management's AstraZeneca position peaked at $222K in Q4 2024.
1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.